HSP90-话题@MedSci

#HSP90#

12篇内容 | 760人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2163209, encodeId=c8db21632093e, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>抑制剂<a href='/topic/show?id=3e5410e036f2' target=_blank style='color:#2F92EE;'>#Tanespimycin#</a> (17-AAG)与<a href='/topic/show?id=b7e38e22888' target=_blank style='color:#2F92EE;'>#荜茇酰胺#</a>联合对<a href='/topic/show?id=3263e877271' target=_blank style='color:#2F92EE;'>#结肠癌#</a>细胞更高效, objectTitle=CDD：HSP90抑制剂与荜茇酰胺联合对结肠癌细胞更高效, objectType=article, longId=796482, objectId=ab4fe96482c8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230930/51c95fdc73914a3593a446afe0296041.jpg, objectUrl=/article/show_article.do?id=ab4fe96482c8, replyNumber=0, likeNumber=52, createdTime=2023-10-17, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ab4fe96482c8, moduleTitle=CDD：HSP90抑制剂与荜茇酰胺联合对结肠癌细胞更高效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab4fe96482c8)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1707670, encodeId=ef531e076709e, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=Br J Dermatol：HSP90抑制剂RGRN-305治疗斑块型银屑病, objectType=article, longId=221385, objectId=293322138531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=293322138531, replyNumber=0, likeNumber=37, createdTime=2021-12-30, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=293322138531, moduleTitle=Br J Dermatol：HSP90抑制剂RGRN-305治疗斑块型银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=293322138531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707669, encodeId=a6211e07669f7, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=Cell Death Dis：USP22依赖性HSP90AB1促进乳腺癌和结直肠癌对HSP90的抑制耐受, objectType=article, longId=185083, objectId=2b5d18508369, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b5d18508369, replyNumber=0, likeNumber=38, createdTime=2020-04-11, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b5d18508369, moduleTitle=Cell Death Dis：USP22依赖性HSP90AB1促进乳腺癌和结直肠癌对HSP90的抑制耐受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b5d18508369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707667, encodeId=cbc21e07667bd, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=Sci Rep：开发新型Hsp90抑制剂NCT-50作为非小细胞肺癌的潜在抗癌药, objectType=article, longId=149225, objectId=90451492254d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90451492254d, replyNumber=0, likeNumber=32, createdTime=2019-04-27, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90451492254d, moduleTitle=Sci Rep：开发新型Hsp90抑制剂NCT-50作为非小细胞肺癌的潜在抗癌药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90451492254d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707668, encodeId=4b0b1e0766860, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=CLIN CANCER RES：BRAF和HSP90抑制剂联合治疗不可切除的黑色素瘤, objectType=article, longId=154006, objectId=cf53154006f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf53154006f7, replyNumber=0, likeNumber=39, createdTime=2018-12-26, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf53154006f7, moduleTitle=CLIN CANCER RES：BRAF和HSP90抑制剂联合治疗不可切除的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf53154006f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707666, encodeId=7b321e0766681, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=联合靶向BRAF和HSP90的药物显示了黑素瘤治疗潜能, objectType=article, longId=136724, objectId=5b79136e249e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b79136e249e, replyNumber=0, likeNumber=29, createdTime=2018-08-12, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b79136e249e, moduleTitle=联合靶向BRAF和HSP90的药物显示了黑素瘤治疗潜能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b79136e249e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707665, encodeId=568b1e07665bb, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=我国科学家定义广谱肿瘤标志物Hsp90α获准用于临床, objectType=article, longId=80446, objectId=acb4804465f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acb4804465f, replyNumber=0, likeNumber=26, createdTime=2017-09-02, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acb4804465f, moduleTitle=我国科学家定义广谱肿瘤标志物Hsp90α获准用于临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acb4804465f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707664, encodeId=78d41e0766440, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=罗永章：Hsp90α是一个全新的肿瘤标志物, objectType=article, longId=48790, objectId=1a8c48e90b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a8c48e90b8, replyNumber=0, likeNumber=41, createdTime=2015-08-29, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a8c48e90b8, moduleTitle=罗永章：Hsp90α是一个全新的肿瘤标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a8c48e90b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707662, encodeId=39601e07662a3, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=罗永章：血浆Hsp90α是一个全新的肿瘤标志物, objectType=article, longId=37360, objectId=ab9b3e36079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab9b3e36079, replyNumber=0, likeNumber=35, createdTime=2015-03-31, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab9b3e36079, moduleTitle=罗永章：血浆Hsp90α是一个全新的肿瘤标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab9b3e36079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707663, encodeId=3e6b1e07663db, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=Clin Cancer Res：人体首例第二代非安莎霉素HSP90抑制剂（AT13387）治疗晚期实体瘤的一期临床试验, objectType=article, longId=41678, objectId=4031416e864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4031416e864, replyNumber=0, likeNumber=35, createdTime=2015-08-03, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4031416e864, moduleTitle=Clin Cancer Res：人体首例第二代非安莎霉素HSP90抑制剂（AT13387）治疗晚期实体瘤的一期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4031416e864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707661, encodeId=dbf31e07661df, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=A＆R：瓜氨酸化Hsp90α/β可能是RA相关肺间质病变的自身抗体标记物, objectType=article, longId=18512, objectId=3cbc1851256, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cbc1851256, replyNumber=0, likeNumber=46, createdTime=2014-04-20, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cbc1851256, moduleTitle=A＆R：瓜氨酸化Hsp90α/β可能是RA相关肺间质病变的自身抗体标记物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cbc1851256)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1707660, encodeId=fe4d1e07660bf, content=<a href='/topic/show?id=b7959158af' target=_blank style='color:#2F92EE;'>#HSP90#</a>, objectTitle=JEM：HSP90抑制物延缓乳腺癌和血癌生长, objectType=article, longId=3932, objectId=64f1393253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64f1393253, replyNumber=0, likeNumber=38, createdTime=2012-12-12, rootId=0, userName=ms5906905816781247, userId=07fd31458035, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64f1393253, moduleTitle=JEM：HSP90抑制物延缓乳腺癌和血癌生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64f1393253)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HSP90

2020-05-29

(审核中...)

前往app查看评论内容

#HSP90#抑制剂#Tanespimycin# (17-AAG)与#荜茇酰胺#联合对#结肠癌#细胞更高效

CDD：HSP90抑制剂与荜茇酰胺联合对结肠癌细胞更高效

2023-10-17发表于上海

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

Br J Dermatol：HSP90抑制剂RGRN-305治疗斑块型银屑病

2021-12-30

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

Cell Death Dis：USP22依赖性HSP90AB1促进乳腺癌和结直肠癌对HSP90的抑制耐受

2020-04-11

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

Sci Rep：开发新型Hsp90抑制剂NCT-50作为非小细胞肺癌的潜在抗癌药

2019-04-27

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

CLIN CANCER RES：BRAF和HSP90抑制剂联合治疗不可切除的黑色素瘤

2018-12-26

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

联合靶向BRAF和HSP90的药物显示了黑素瘤治疗潜能

2018-08-12

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

我国科学家定义广谱肿瘤标志物Hsp90α获准用于临床

2017-09-02

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

罗永章：Hsp90α是一个全新的肿瘤标志物

2015-08-29

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

罗永章：血浆Hsp90α是一个全新的肿瘤标志物

2015-03-31

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

Clin Cancer Res：人体首例第二代非安莎霉素HSP90抑制剂（AT13387）治疗晚期实体瘤的一期临床试验

2015-08-03

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

A＆R：瓜氨酸化Hsp90α/β可能是RA相关肺间质病变的自身抗体标记物

2014-04-20

ms5906905816781247 (审核中...)

前往app查看评论内容

#HSP90#

JEM：HSP90抑制物延缓乳腺癌和血癌生长

2012-12-12

科室
- - 订阅+
  - 更多科室
工具
服务